Publication:
Epitheloid hemangioendothelioma of the palpebral lobe of the lacrimal gland

dc.contributor.coauthorKıratlı, Hayyam
dc.contributor.coauthorTarlan, Berçin
dc.contributor.departmentKUH (Koç University Hospital)
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorRuacan, Ahmet Şevket
dc.contributor.schoolcollegeinstituteKUH (KOÇ UNIVERSITY HOSPITAL)
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:26:08Z
dc.date.issued2013
dc.description.abstractPurpose: To describe a case of an epitheloid hemangioendothelioma which is a tumor of endothelial origin with borderline malignancy between hemangioma and angiosarcoma and which is very rare in the orbit. Methods: Clinical features, results of imaging and histopathological studies and postoperative clinical course of a 22-year-old female patient who presented with a gradual swelling of the left upper eyelid were reviewed. Results: Magnetic resonance imaging studies suggested a solid lesion with moderate contrast enhancement in the palpebral lobe of the lacrimal gland. A short course of systemic corticosteroid therapy failed to resolve the lesion. Excisional biopsy of the tumor yielded the diagnosis of epitheloid hemangioendothelioma of the lacrimal gland. The tumor was composed of nests of epitheloid cells, some forming CD31 positive intracytoplasmic vascular channels containing erythrocytes. CD34 and EMA were also positive and desmin, SMA, p63, S100, Factor VIII and HHV-8 were negative on immunohistochemical studies. During 44 months of follow-up, there has been no recurrence or systemic metastasis. Conclusion: Epitheloid hemangioendothelioma can occur in the palpebral lobe of the lacrimal gland as a hard, painless, immobile mass. Simple excisional biopsy of the tumor, assumed to have an intermediate malignancy grade, without further local or systemic therapy provided a disease-free 3-year survival.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue2
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume32
dc.identifier.doi10.3109/01676830.2013.764443
dc.identifier.eissn1744-5108
dc.identifier.issn0167-6830
dc.identifier.scopus2-s2.0-84876040110
dc.identifier.urihttps://doi.org/10.3109/01676830.2013.764443
dc.identifier.urihttps://hdl.handle.net/20.500.14288/11498
dc.identifier.wos415524700008
dc.keywordsEpitheloid hemangioendothelioma
dc.keywordsLacrimal gland
dc.keywordsOrbit
dc.keywordsPalpebral lobe
dc.language.isoeng
dc.publisherTaylor & Francis Inc
dc.relation.ispartofOrbit-An International Journal On Orbital Disorders and Facial Reconstructive Surgery
dc.subjectOphthalmology
dc.titleEpitheloid hemangioendothelioma of the palpebral lobe of the lacrimal gland
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorRuacan, Ahmet Şevket
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit1KUH (KOÇ UNIVERSITY HOSPITAL)
local.publication.orgunit2KUH (Koç University Hospital)
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isParentOrgUnitOfPublication055775c9-9efe-43ec-814f-f6d771fa6dee
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery055775c9-9efe-43ec-814f-f6d771fa6dee

Files